Who makes ADC-189 and Itraconazole?

ADC-189 and Itraconazole is developed by Jiaxing AnDiCon Biotech Co.,Ltd.

What development phase is ADC-189 and Itraconazole in?

ADC-189 and Itraconazole is in Phase 1.

Last reviewed 2026-04-23 · How we verify

ADC-189 and Itraconazole

Jiaxing AnDiCon Biotech Co.,Ltd · Phase 1 active Small molecule

At a glance

Generic name	ADC-189 and Itraconazole
Also known as	Part 1: Single dose of ADC-189; Part 2: Itraconazole with single dose of ADC-189
Sponsor	Jiaxing AnDiCon Biotech Co.,Ltd
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Drug-Drug Interaction (DDI) Study of ADC189 With Itraconazole in Healthy, Adult Subjects (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

ADC-189 and Itraconazole CI brief — competitive landscape report
ADC-189 and Itraconazole updates RSS · CI watch RSS
Jiaxing AnDiCon Biotech Co.,Ltd portfolio CI